Video

VIDEO: Dr. Alexis Ogdie discusses the latest research in psoriatic arthritis


 

What's new with potential treatment options such as tildrakizumab? Given the roles obesity and metabolic disease play in psoriatic arthritis, how does weight loss affect treatment response? Alexis Ogdie, MD, director of the psoriatic arthritis clinic at the University of Pennsylvania in Philadelphia, talks about the latest developments in psoriatic arthritis research.

Recommended Reading

Psoriatic Arthritis Journal Scan: May 2019
Psoriatic Arthritis Resource Center
Carotid ultrasound may aid cardiovascular risk stratification of patients with psoriatic disease
Psoriatic Arthritis Resource Center
Ixekizumab surpasses adalimumab in PsA head-to-head study
Psoriatic Arthritis Resource Center
VIDEO: Dr. Lihi Eder on the diagnostic challenges of psoriatic arthritis
Psoriatic Arthritis Resource Center
Obesity might be targetable driver of psoriatic arthritis progression
Psoriatic Arthritis Resource Center
Infections linked with transition to psoriatic arthritis
Psoriatic Arthritis Resource Center
Psoriatic Arthritis Journal Scan: June 2019
Psoriatic Arthritis Resource Center
PsA Fast Facts: PsA and psoriasis links
Psoriatic Arthritis Resource Center
EULAR keeps csDMARDs as top PsA drugs
Psoriatic Arthritis Resource Center
Unacceptable pain despite inflammation control commonly occurs in PsA patients
Psoriatic Arthritis Resource Center